Last ¥176.00 JPY
Change Today 0.00 / 0.00%
Volume 6.2M
4208 On Other Exchanges
As of 2:00 AM 07/28/14 All times are local (Market data is delayed by at least 15 minutes).

ube industries ltd (4208) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/17/14 - ¥239.00
52 Week Low
05/15/14 - ¥163.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for UBE INDUSTRIES LTD (4208)

Related News

No related news articles were found.

ube industries ltd (4208) Related Businessweek News

No Related Businessweek News Found

ube industries ltd (4208) Details

Ube Industries, Ltd., together with its subsidiaries, is engaged in chemicals and plastics, specialty chemicals and products, pharmaceuticals, cement and construction materials, machinery and metals, and energy and environment businesses. Its Chemicals & Plastics segment offers synthetic rubber; and caprolactam chain products, including caprolactam, nylon resins, and industrial chemicals. The company’s Specialty Chemicals & Products segment provides various specialty products, such as polyimide, high purity chemicals, separation membranes, ceramics, telecommunication devices, aerospace materials, and battery materials, including electrolytes and separators; and fine chemicals. Its Pharmaceuticals segment offers a range of active ingredients and intermediates for anti allergic drugs and antihypertensive agents; and manufactures active pharmaceutical ingredients for generic drugs for new drugs under contract for pharmaceutical companies. The company’s Cement & Construction Materials segment provides cement, limestone, ready-mixed concrete, calcia and magnesia, and specialty inorganic materials; building materials comprising self-leveling materials, plastering materials, and waterproofing materials; and resource recycling. Its Machinery & Metal Products segment offers molding machines, including die-casting and injection molding machines; industrial machinery, bridges, and steel structures; and steel making products. The company’s Energy & Environment segment is engaged sale of coal; and independent power production. It has operations in Japan, Asia, Europe, and other. UBE Industries, Ltd. was founded in 1897 and is headquartered in Tokyo, Japan.

11,225 Employees
Last Reported Date: 06/27/14
Founded in 1897

ube industries ltd (4208) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ube industries ltd (4208) Key Developments

Ube Industries, Ltd. Approves Year End Cash Dividend for the Year Ended March 31, 2014

Ube Industries, Ltd. announced that at the ordinary general meeting held on June 27, 2014, the shareholders approved including a distribution of a year-end cash dividend at the rate of ¥5 per share. The dividend is for the 108th fiscal year ended March 31, 2014. The payment period at the Japan Post Bank is from June 30, 2014 to July 31, 2014.

Ube Industries, Ltd. Reports Earnings Results for the Year Ended March 31, 2014; Provides Earnings Guidance for the Year Ending March 31, 2015

Ube Industries, Ltd. reported earnings results for the year ended March 31, 2014. The company has reported that net income for the year ended March 31, 2014 was JPY 12.6 billion, or JPY 12.16 per share, compared to JPY 8.2 billion, or JPY 8.22 per share, for the year ended March 31, 2013. Net sales for the year ended March 31, 2014 were JPY 650.5 billion, compared to JPY 626 billion for the year ended March 31, 2013. Operating income for the year ended March 31, 2014 was JPY 24.4 billion, compared to JPY 29.9 billion for the year ended March 31, 2013. Ordinary income for the year ended March 31, 2014 was JPY 18.6 billion, compared to JPY 28 billion for the year ended March 31, 2013. For the year ending March 31, 2015, the company expected net income to be JPY 13.5 billion, and net income per share to be JPY 12.76. For the year ending March 31, 2015, the company expected net sales to be JPY 670 billion, operating income to be JPY 30 billion, and ordinary income to be JPY 24 billion.

Ube Industries Announces Launch of Antiplatelete Agent Efient 3.75mg/5mg Tablets in Japan

Ube Industries, Ltd. announced that antiplatelet agent Efient® 3.75mg/5mg Tablets has been launched in Japan by Daiichi Sankyo Company, Limited. The agent was jointly developed by the two companies. Efient® is an oral antiplatelet agent discovered by Ube Industries and its research partner, Daiichi Sankyo. The results of clinical trials in Japanese patients with ischemic heart disease undergoing percutaneous coronary intervention (PCI) demonstrated that Efient® reduces the incidence of ischemic events from the perioperative period of PCI by rapidly reducing platelet aggregation activity. Outside of Japan, based on co-development by Daiichi Sankyo and Eli Lilly and Company, the European Commission and the US FDA granted marketing authorization for Efient®/Effient® for the prevention of atherothrombotic events in patients with acute coronary syndrome (ACS) undergoing PCI, in combination with aspirin, in 2009.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4208:JP ¥176.00 JPY 0.00

4208 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arkema SA €71.00 EUR +0.27
EMS-Chemie Holding AG SFr.394.50 CHF -8.50
Honeywell International Inc $95.76 USD 0.00
Polypore International Inc $44.07 USD 0.00
SK Innovation Co Ltd 103,000 KRW -1,000.00
View Industry Companies

Industry Analysis


Industry Average

Valuation 4208 Industry Range
Price/Earnings 14.7x
Price/Sales 0.3x
Price/Book 0.8x
Price/Cash Flow 15.0x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UBE INDUSTRIES LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at